Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02569801
Title A Study of GDC-0810 Versus Fulvestrant in Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Genentech, Inc.
Indications

estrogen-receptor positive breast cancer

Therapies

GDC-0810

Fulvestrant

Age Groups: adult
Covered Countries USA


No variant requirements are available.